SCHEMBL4682033

SCHEMBL4682033

CCc1cccc(C(C)C([NH])=O)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 4/20 0.51
AKR1C3 P42330 1/20 0.47
AKR1C2 P52895 1/20 0.47
BCL2 P10415 1/20 0.41
PTGS1 P23219 3/20 0.39
MAPT P10636 3/20 0.39
SMN1; SMN2 Q16637 3/20 0.39
CXCR1 P25024 2/20 0.39
CXCR2 P25025 2/20 0.39
MAPK1 P28482 2/20 0.39
CYP3A4 P08684 2/20 0.39
RECQL P46063 1/20 0.39
KDM4E B2RXH2 1/20 0.39
ALDH1A1 P00352 1/20 0.39
LMNA P02545 1/20 0.39
HPGD P15428 1/20 0.39
PMP22 Q01453 1/20 0.39
SLC22A6 Q4U2R8 1/20 0.39
HSD17B10 Q99714 1/20 0.39
CXCL8 P10145 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3674499 0.84 PTGS2 (0.69) PTGS2AKR1C3AKR1C2BCL2PTGS1
SCHEMBL4682035 0.83 PTGS2 (0.51) PTGS2AKR1C3AKR1C2BCL2PTGS1
SCHEMBL11212803 0.81 PTGS2 (0.43) PTGS2AKR1C3AKR1C2BCL2MAPT
SCHEMBL8329361 0.77 CCR5 (0.49) PTGS2AKR1C3AKR1C2SMN1; SMN2ALOX5
SCHEMBL18242301 0.76 PTGS2 (0.46) PTGS2AKR1C3AKR1C2BCL2MAPT
SCHEMBL3919972 0.76 PTGS2 (0.46) PTGS2AKR1C3AKR1C2BCL2CYP3A4
SCHEMBL3919970 0.76 PTGS2 (0.46) PTGS2AKR1C3AKR1C2BCL2CYP3A4
SCHEMBL4681610 0.76 AKR1C3 (0.52) PTGS2AKR1C3AKR1C2PTGS1SMN1; SMN2
SCHEMBL14420087 0.75 PTGS2 (0.45) PTGS2AKR1C3AKR1C2BCL2PTGS1
SCHEMBL11873206 0.75 PTGS2 (0.45) PTGS2AKR1C3AKR1C2BCL2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1902717-A2 Vasopressin antagonist and oxytocin antagonist Otsuka Pharmaceutical Company, Limited (JP) 2008-03-26 EP disclosed
EP-0620003-B1 VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST OTSUKA PHARMA CO LTD (JP) 2008-01-16 EP disclosed
US-5753644-A Vasopressin antagonist and oxytocin antagonist OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1998-05-19 US disclosed
US-5622947-A VASODILATORS, HYPOTENSIVE AGENTS, DIURETICS, PLATELET AGGLUTINATION INHIBITORS; ALSO USED TO PREVENT PREMATURE BIRTH, TREAT DYSMENORRHEA OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-04-22 US disclosed
EP-0514667-B1 Benzazepin derivatives as vasopressin antagonists OTSUKA PHARMA CO LTD (JP) 1995-08-09 EP disclosed
EP-0620003-A1 VASOPRESSIN ANTAGONIST AND OXYTOCIN ANTAGONIST OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1994-10-19 EP disclosed
US-5244898-A Vasopressin antagonist OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1993-09-14 US disclosed
EP-0514667-A1 Benzazepin derivatives as vasopressin antagonists OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-25 EP disclosed